Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Cytiva expanding US operations beyond the East Coast

    Jul 14, 2022, 09:31 AM by
    Full story
  • Sharp expands clinical services operations at its EU Heerenveen facility

    Jul 14, 2022, 09:30 AM by
    About Sharp Sharp is a global leader in clinical supply chain services and pharmaceutical packaging. For more than 65 years, we’ve provided solutions to pharma and biotech clients from phase I trials through to commercial launch and lifecycle management. With facilities in the United States, United Kingdom, Belgium and the Netherlands and 30+ clinical depots globally, covering every region of the world, we are engineered to deliver. Through our partnership with Berkshire Sterile Manufacturing we offer specialist isolator-based filling of vials, syringes, cartridges and containers, as well as lyophilization and terminal sterilization. Our full complement of integrated services includes: research and development, clinical manufacturing, primary and secondary packaging of both investigational and commercial product, package design, serialization and aggregation, storage and distribution and clinical IRT. Sharp also offers Qualified Person (QP) services to meet the complex regulatory demands of the EU and UK.
    Full story
  • Oak Ridge Researchers ID Proteins that Can Block Tumor Growth Pathway

    Jul 14, 2022, 01:00 AM by User Not Found
    Bio-IT World | Researchers at the Department of Energy’s Oak Ridge National Laboratory have definitively linked the function of a specific domain of proteins to the activation—and deactivation—of the c-MET pathway, which leads to the progression of tumor growth and metastatic cancer cells. Mutating any of four proteins blocks pathway progression.
    Full story
  • Connect in Pharma launches art exhibition and charity partnership to raise funds for rare disease research

    Jul 13, 2022, 09:24 AM by
    The organisers of Connect in Pharma announce today that for every visitor to the Geneva-based event, five Swiss francs will be donated to EspeRare Foundation, a not-for-profit organisation that identifies, develops and promotes access to life-changing treatments and technologies for patients affected by rare diseases.
    Full story
  • Bioprocess Containers Market Global Industry Insights, Size and Share 2019 to 2028

    Jul 13, 2022, 09:23 AM by
    The bioprocess containers market is segmented based on by type, by application, by end user and by geography.
    Full story
  • Discovery Life Sciences Acquires AllCells

    Jul 13, 2022, 09:21 AM by
    The global gene therapy market is expected to grow to $5.02B by 2028. It’s slated to be the fastest growing investive market in the world over the next 5 years. Helping fuel this growth, Discovery Life Sciences, the biospecimen and biomarker specialists, has acquired AllCells, a leading provider of clinical-grade (GMP-compliant) and Research Use Only primary cell products. With more than 30 years of joint cell and gene therapy experience, the two companies' combined solutions will: Establish the premier provider for critical starting materials and analytic services to accelerate CGT applications Create one of the industry's largest dedicated client donor pools Provide a “one-stop-shop” for revolutionary products and services with greater speed and reliability to satisfy the entire CGT continuum Offer continuity for every stage of development, spanning RUO and GMP grade fresh, cryopreserved, and mobilized leukoplaks, as well as immune cell isolations, diseased biospecimens, and expert analytical service Effective immediately, AllCells CEO and President Danny Zheng will lead the combined entity. I’m happy to set up an interview with him to discuss the news in further detail. Thank you and please feel free to reach out with questions -
    Full story
  • Global Precision Medicine Software Market is projected to witness a healthy growth rate of 10% in the upcoming years

    Jul 12, 2022, 09:37 AM by
    The global precision medicine software market is driven by growing research in genomics/precision medicine, significant VC fundings, rising government support and the rapid shift toward personalized treatments.
    Full story
  • BioIVT Launches New Scientific Advisory Board

    Jul 12, 2022, 09:35 AM by
    Its new Board members will provide expert insight into ADME-Tox, biomarker, assay, cell and gene therapy, and immuno-oncology advances.
    Full story
  • Cotiviti’s Quality Intelligence Earns NCQA Certified Measures Status for the 2022 Measurement Year

    Jul 12, 2022, 09:35 AM by
    22nd consecutive year that Cotiviti’s solution has passed rigorous NCQA review process
    Full story
  • St. Jude Sickle Cell Research Team Warns Geneticists to Choose ‘the Right Mouse for the Job’

    Jul 12, 2022, 01:00 AM by User Not Found
    Bio-IT World | Mitchell Weiss and fellow St. Jude team members devised autologous hematopoietic stem cell gene-editing techniques with hopes of curing sickle cell disease, but not without the “right mouse for the job.”
    Full story
  • 3DR Labs Introduces New Imaging Services to Meet Specific Radiology Market Needs

    Jul 11, 2022, 09:52 AM by
    Its new Cardiac Center of Excellence and Imaging Excellence Advisory Services are designed to support radiology departments nationwide.
    Full story
  • Celegence adds report writing functionality to EU MDR & IVDR compliance technology CAPTIS™ to help streamline medical writing and document maintenance

    Jul 11, 2022, 09:50 AM by
    Celegence, a global provider of regulatory affairs services and solutions for the life sciences industry, has today announced the addition of new features to CAPTIS™ to help the device and diagnostic industry produce compliant Post Market Surveillance (PMS) documentation more efficiently.
    Full story
  • Analytical Standards Market Size, Technique, and Forecast to 2028

    Jul 8, 2022, 09:42 AM by
    Global analytical standards market is analysed based on product, technique, methodology, category and geography.
    Full story
  • For Drug Discovery Research, Laboratory Automation Needs to Be Flexible

    Jul 8, 2022, 01:00 AM by User Not Found
    Bio-IT World | Scientists who want to implement automation in their laboratories should choose an infrastructure that can provide long-term flexibility for their teams. Increasing productivity with automation is essential to make that vision possible, and flexibility is critical for researchers to change workflows and take on new priorities quickly.
    Full story
  • Drug Repurposing Strategy Without An ‘Answer Book’

    Jul 7, 2022, 01:00 AM by User Not Found
    Bio-IT World | Scientists working in the information biology lab at Hokkaido University in Japan have come up with a drug repurposing strategy combining machine learning, unsupervised clustering of gene expression, and two-stage prediction.
    Full story
  • CloudLIMS Exhibits its Secure Medical and Healthcare LIMS @ 2022 AACC, Chicago

    Jul 6, 2022, 09:23 AM by
    CloudLIMS is exhibiting @2022 AACC Annual Scientific Meeting & Clinical Lab Expo and showcasing its Medical & Healthcare LIMS at Booth 464 from July 26 - 28 in Chicago.
    Full story
  • WHO calls for new innovations to tackle antimicrobial resistance crisis

    Jul 6, 2022, 09:21 AM by
    With only a few antibiotics in clinical development, new technologies, especially ones that do not develop antimicrobial resistance, are needed to treat healthcare-associated infections. An innovation from UCL in London and developed by Canadian life sciences company, Ondine Biomedical, uses photodisinfection to kill infection-causing pathogens, including viruses, bacteria, and fungi.
    Full story
  • DFE Pharma expands its inhalation portfolio with the launch of Lactohale® 400

    Jul 5, 2022, 09:43 AM by
    DFE Pharma expands its inhalation portfolio with the launch of Lactohale® 400 Being a leader in Dry Powder Inhalation, DFE Pharma further expands its broad excipient portfolio of inhalation grade lactose
    Full story
  • CD Formulation Enlarges Particulate Matter Testing Capability

    Jul 5, 2022, 09:42 AM by
    Full story
  • A Comprehensive Portfolio of Hydrophobic Polymers Makes Breakthroughs Closer

    Jul 5, 2022, 09:40 AM by
    Full story
  • «
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128 (current)
  • 129
  • 130
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy